| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
98,689 |
95,566 |
$6.95M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
47,048 |
45,601 |
$4.35M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
29,516 |
28,305 |
$2.75M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
24,171 |
24,000 |
$2.41M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17,135 |
17,030 |
$1.64M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,114 |
5,087 |
$520K |
| 99215 |
Prolong outpt/office vis |
1,497 |
1,453 |
$216K |
| 92551 |
|
29,894 |
29,619 |
$204K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
2,453 |
2,390 |
$187K |
| 90670 |
|
11,844 |
11,735 |
$171K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,108 |
1,090 |
$147K |
| 90698 |
|
9,050 |
8,973 |
$133K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,628 |
2,462 |
$131K |
| 90688 |
|
9,044 |
8,976 |
$118K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,548 |
2,484 |
$112K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,475 |
3,038 |
$84K |
| 90680 |
|
5,208 |
5,176 |
$80K |
| 90686 |
|
4,786 |
4,747 |
$68K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,643 |
8,488 |
$67K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
483 |
481 |
$66K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
748 |
739 |
$64K |
| 90837 |
Psychotherapy, 53 minutes with patient |
790 |
525 |
$62K |
| 94010 |
|
3,238 |
3,192 |
$58K |
| 87430 |
|
3,977 |
3,915 |
$55K |
| 95115 |
|
9,251 |
3,167 |
$51K |
| 90744 |
|
3,291 |
3,246 |
$48K |
| 90633 |
|
2,640 |
2,622 |
$41K |
| 95012 |
|
3,568 |
3,536 |
$38K |
| 99173 |
|
20,102 |
19,927 |
$34K |
| 90677 |
|
2,509 |
2,493 |
$34K |
| 95117 |
|
3,510 |
1,253 |
$22K |
| 36416 |
|
10,765 |
10,521 |
$21K |
| 99499 |
|
737 |
736 |
$20K |
| 95024 |
|
163 |
162 |
$19K |
| 85018 |
|
7,369 |
7,277 |
$15K |
| 99383 |
|
110 |
107 |
$11K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
178 |
178 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,158 |
1,138 |
$9K |
| 90480 |
|
247 |
243 |
$8K |
| 87070 |
|
1,118 |
1,094 |
$8K |
| 90685 |
|
487 |
484 |
$7K |
| 99429 |
|
755 |
752 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
430 |
428 |
$7K |
| 99460 |
|
79 |
77 |
$6K |
| 90707 |
|
358 |
357 |
$5K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
99 |
96 |
$5K |
| D0120 |
Periodic oral evaluation - established patient |
190 |
185 |
$5K |
| 90658 |
|
365 |
363 |
$5K |
| 90651 |
|
412 |
405 |
$5K |
| 96127 |
|
1,616 |
1,583 |
$5K |
| D9999 |
Unspecified adjunctive procedure, by report |
186 |
181 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
69 |
56 |
$4K |
| 92552 |
|
185 |
185 |
$4K |
| 90716 |
|
216 |
215 |
$4K |
| 90656 |
|
519 |
515 |
$4K |
| 90734 |
|
364 |
359 |
$4K |
| D1206 |
Topical application of fluoride varnish |
189 |
185 |
$3K |
| 94060 |
|
125 |
120 |
$3K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
73 |
71 |
$3K |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
117 |
116 |
$2K |
| 99381 |
|
25 |
25 |
$2K |
| 90700 |
|
165 |
161 |
$2K |
| 90715 |
|
204 |
203 |
$2K |
| 0071A |
|
51 |
51 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
53 |
52 |
$2K |
| 90710 |
|
145 |
144 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
481 |
468 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
27 |
27 |
$2K |
| 96161 |
|
841 |
828 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
180 |
172 |
$1K |
| 90696 |
|
99 |
99 |
$1K |
| 90672 |
|
83 |
82 |
$1K |
| 90619 |
|
83 |
83 |
$1K |
| 99188 |
|
97 |
97 |
$1K |
| 96380 |
|
77 |
77 |
$1K |
| 90681 |
|
337 |
329 |
$996.00 |
| 94664 |
|
98 |
97 |
$938.34 |
| 81002 |
|
338 |
324 |
$911.92 |
| 90834 |
Psychotherapy, 45 minutes with patient |
13 |
12 |
$888.15 |
| 87807 |
|
72 |
70 |
$880.07 |
| 90648 |
|
57 |
54 |
$827.64 |
| 99177 |
|
258 |
258 |
$772.06 |
| 81003 |
|
365 |
360 |
$764.13 |
| 0002A |
|
14 |
14 |
$588.00 |
| 86756 |
|
31 |
31 |
$442.68 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
150 |
148 |
$430.77 |
| 88720 |
|
64 |
51 |
$320.50 |
| 36415 |
Collection of venous blood by venipuncture |
43 |
43 |
$99.39 |
| 90474 |
|
17 |
17 |
$23.31 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
38 |
38 |
$0.89 |
| 90381 |
|
37 |
37 |
$0.37 |
| 99072 |
|
6,379 |
5,834 |
$0.00 |
| 1159F |
|
3,778 |
3,532 |
$0.00 |
| 1160F |
|
1,914 |
1,847 |
$0.00 |